Scientific interest in this biological mechanism in relation to leukemia has increased in recent years due to the discovery of specific agents targeted against BCL-2 that have demonstrated efficacy in chronic lymphocytic leukemia (CLL) and AML [15]. The gene discussed is BCL2; the disease is acute myeloid leukemia.